HIGHLIGHTS
- who: Washington and colleagues from the University of have published the paper: University of Washington, Seattle, Washington University of Alabama at Birmingham, Birmingham, Washington , in the Journal: (JOURNAL)
SUMMARY
Poster Abstracts cardiovascular (rVE=13.1%, 95%CI:10.5-15.7%), and cardiorespiratory events (rVE=17.9%, 95%CI:15.0-20.8%); and all-causes (rVE=8.4%, 95%CI:5.7-11.0%). Pooled rVEs were similar in sub-analyses by dominant strain, antigenic match, and study type/setting. While all adults 65+ benefited from the use of HD-IIV, age . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.